Aging, Cellular Senescence, and Progressive Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Aging is one of the most important risk factors for the development of several neurodegenerative diseases including progressive multiple sclerosis (MS). Cellular senescence (CS) is a key biological process underlying aging. Several stressors associated with aging and MS pathology, such as oxidative stress, mitochondrial dysfunction, cytokines and replicative exhaustion are known triggers of cellular senescence. Senescent cells exhibit stereotypical metabolic and functional changes, which include cell-cycle arrest and acquiring a pro-inflammatory phenotype secreting cytokines, growth factors, metalloproteinases and reactive oxygen species. They accumulate with aging and can convert neighboring cells to senescence in a paracrine manner. In MS, accelerated cellular senescence may drive disease progression by promoting chronic non-remitting inflammation, loss or altered immune, glial and neuronal function, failure of remyelination, impaired blood-brain barrier integrity and ultimately neurodegeneration. Here we discuss the evidence linking cellular senescence to the pathogenesis of MS and the putative role of senolytic and senomorphic agents as neuroprotective therapies in tackling disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · cited 1×
“Cellular senescence (CS) has been recognized as a key biological process underling normal aging (López-Otín et al., 2013; Gorgoulis et al., 2019) and evidence suggest that the accumulation of senescent cells with time may contribute to the pathogenesis of age-related and neurodegenerative disease (Kritsilis et al.”
BackgroundThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“Lifelong elimination of p16INK4A cells in BubR1 progeroid mice by activation of an INK-ATTAC transgene substantially delayed age-related disease, whereas late life elimination of p16INK4A cells attenuated these age-related pathologies (Baker et al., 2011).”
BackgroundAgeing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310 · cited 1×
“Aging is the most important risk factor for the development of neurodegenerative disease (Hou et al., 2019).”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 2×
“Cellular senescence (CS) has been recognized as a key biological process underling normal aging (López-Otín et al., 2013; Gorgoulis et al., 2019) and evidence suggest that the accumulation of senescent cells with time may contribute to the pathogenesis of age-related and neurodegenerative disease (Kritsilis et al.”
BackgroundSelf-citationCellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
Ming, G.-L., & Song, H. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.001 · Cited by 2,651 · cited 1×
“They are thought to primarily reside in the subventricular zone (SVZ) and the subgranular zone (SGZ) of the dentate gyrus (Kriegstein and Alvarez-Buylla, 2009; Ming and Song, 2011).”
BackgroundThe Glial Nature of Embryonic and Adult Neural Stem Cells
Kriegstein, A., & Alvarez-Buylla, A. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135600 · Cited by 2,475 · cited 1×
“They are thought to primarily reside in the subventricular zone (SVZ) and the subgranular zone (SGZ) of the dentate gyrus (Kriegstein and Alvarez-Buylla, 2009; Ming and Song, 2011).”
BackgroundA complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 2×
“These are capable of affecting neighboring cells and converting them to senescence in a paracrine manner (Kuilman and Peeper, 2009; Acosta et al., 2013).”
BackgroundResultFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 3×
“The number of senescent cells increases with age (Rodier and Campisi, 2011).”
Background
Research works printed but not linked: 71
- Al-Mashhadi, 2015, Oxidative glial cell damage associated with white matter lesions in the aging human brain, Brain Pathol, 25, 565, 10.1111/bpa.12216 · DOI · Paper page
- Ayad, 2018, Regulation of p38 mitogen-activated kinase-mediated fetal membrane senescence by statins, Am. J. Reprod. Immunol., 80, e12999, 10.1111/aji.12999 · DOI
- Barbouti, 2019, In situ evidence of cellular senescence in thymic epithelial cells (TECs) during human thymic involution, Mech. Ageing Dev, 177, 88, 10.1016/j.mad.2018.02.005 · DOI · Paper page
- Berthiaume, 2018, Pericyte structural remodeling in cerebrovascular health and homeostasis, Front. Aging Neurosci, 10, 210, 10.3389/fnagi.2018.00210 · DOI
- Bose, 2010, Glucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterations, Cell Death Dis, 1, e92, 10.1038/cddis.2010.60 · DOI
- Bramow, 2010, Demyelination versus remyelination in progressive multiple sclerosis, Brain, 133, 2983, 10.1093/brain/awq250 · DOI · Paper page
- Broux, 2015, IL-15 amplifies the pathogenic properties of CD4+CD28− T cells in multiple sclerosis, J. Immunol, 194, 2099, 10.4049/jimmunol.1401547 · DOI
- Broux, 2012, CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients, J. Autoimmun., 38, 10, 10.1016/j.jaut.2011.11.006 · DOI
- Castellazzi, 2020, Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient, Fluids Barriers CNS, 17, 14, 10.1186/s12987-020-0173-2 · DOI
- Chang, 2008, Neurogenesis in the chronic lesions of multiple sclerosis, Brain, 131, 2366, 10.1093/brain/awn157 · DOI
- Chataway, 2014, Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial, Lancet, 383, 2213, 10.1016/S0140-6736(13)62242-4 · DOI · Paper page
- Christian, 2014, Functions and dysfunctions of adult hippocampal neurogenesis, Annu. Rev. Neurosci, 37, 243, 10.1146/annurev-neuro-071013-014134 · DOI · Paper page
- Claes, 2016, Age-associated B cells with proinflammatory characteristics are expanded in a proportion of multiple sclerosis patients, J. Immunol, 197, 4576, 10.4049/jimmunol.1502448 · DOI · Paper page
- Cole, 2020, Accelerated brain ageing and disability in multiple sclerosis, Ann Neurol, 10.1101/584888 · DOI
- Compston, 2008, Multiple sclerosis, Lancet, 372, 1502, 10.1016/S0140-6736(08)61620-7 · DOI · Paper page
- Danilov, 2006, Neurogenesis in the adult spinal cord in an experimental model of multiple sclerosis, Eur. J. Neurosci, 23, 394, 10.1111/j.1460-9568.2005.04563.x · DOI
- Davalos, 2012, Fibrinogen as a key regulator of inflammation in disease, Semin. Immunopathol, 34, 43, 10.1007/s00281-011-0290-8 · DOI · Paper page
- Davalos, 2012, Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation, Nat. Commun., 3, 1227, 10.1038/ncomms2230 · DOI · Paper page
- De Stefano, 2016, Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 87, 93, 10.1136/jnnp-2014-309903 · DOI · Paper page
- Ding, 2020, Waking up quiescent neural stem cells: molecular mechanisms and implications in neurodevelopmental disorders, PLoS Genet., 16, e1008653, 10.1371/journal.pgen.1008653 · DOI
- Elkjaer, 2019, Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis, Acta Neuropathol. Commun., 7, 205, 10.1186/s40478-019-0855-7 · DOI
- Filippi, 2013, Gray matter damage predicts the accumulation of disability 13 years later in MS, Neurology, 81, 1759, 10.1212/01.wnl.0000435551.90824.d0 · DOI · Paper page
- Filippi, 2012, Association between pathological and MRI findings in multiple sclerosis, Lancet Neurol., 11, 349, 10.1016/S1474-4422(12)70003-0 · DOI · Paper page
- Fisniku, 2008, Gray matter atrophy is related to long-term disability in multiple sclerosis: GM atrophy and disability in MS, Ann. Neurol., 64, 247, 10.1002/ana.21423 · DOI · Paper page
- Franklin, 2015, Glia disease and repair- Remyelination, Cold Spring Harb. Perspect. Biol, 7, 1, 10.1101/cshperspect.a020594 · DOI · Paper page
- Görg, 2015, Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy, Glia, 63, 37, 10.1002/glia.22731 · DOI
- Habib, 2020, Association between shorter leukocyte telomeres and multiple sclerosis, J. Neuroimmunol., 341, 577187, 10.1016/j.jneuroim.2020.577187 · DOI
- Haider, 2011, Oxidative damage in multiple sclerosis lesions, 134, 1914, 10.1093/brain/awr128 · DOI · Paper page
- Hampton, 2012, Focal immune-mediated white matter demyelination reveals an age associated increase in axonal vulnerability and decreased remyelination efficiency, Am. J. Pathol, 180, 1897, 10.1016/j.ajpath.2012.01.018 · DOI
- Hemmer, 2015, Role of the innate and adaptive immune responses in the course of multiple sclerosis, Lancet Neurol., 14, 406, 10.1016/S1474-4422(14)70305-9 · DOI · Paper page
- Høgestøl, 2019, Cross-sectional and longitudinal MRI brain scans reveal accelerated brain aging in multiple sclerosis, Front. Neurol., 10, 450, 10.3389/fneur.2019.00450 · DOI
- Hollands, 2017, Depletion of adult neurogenesis exacerbates cognitive deficits in Alzheimer's disease by compromising hippocampal inhibition, Mol. Neurodegener, 12, 64, 10.1186/s13024-017-0207-7 · DOI · Paper page
- Horiuchi, 2012, Amyloid β1-42 oligomer inhibits myelin sheet formation in vitro, Neurobiol. Aging, 33, 499, 10.1016/j.neurobiolaging.2010.05.007 · DOI
- Hou, 2018, Ginsenoside F1 suppresses astrocytic senescence-associated secretory phenotype, Chem. Biol. Interact, 283, 75, 10.1016/j.cbi.2018.02.002 · DOI
- Hou, 2017, Ginsenoside Rg3 prevents oxidative stress-induced astrocytic senescence and ameliorates senescence paracrine effects on glioblastoma, Molecules., 22, 1516, 10.3390/molecules22091516 · DOI
- Ikeda, 2010, DNA damage detected with gammaH2AX in endometrioid adenocarcinoma cell lines, Int. J. Oncol., 36, 1081, 10.3892/ijo_00000589 · DOI
- Johansson, 1999, Neural stem cells in the adult human brain, Exp. Cell Res, 253, 733, 10.1006/excr.1999.4678 · DOI · Paper page
- Kirkwood, 2011, On the programmed/non-programmed nature of ageing within the life history, Curr. Biol, 21, R701, 10.1016/j.cub.2011.07.020 · DOI · Paper page
- Kornek, 2000, Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions, Am. J. Pathol, 157, 267, 10.1016/S0002-9440(10)64537-3 · DOI · Paper page
- Krysko, 2019, Telomere length is associated with disability progression in multiple sclerosis, Ann. Neurol, 86, 671, 10.1002/ana.25592 · DOI
- Kuhlmann, 2008, Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis, Brain, 131, 1749, 10.1093/brain/awn096 · DOI · Paper page
- Li, 2016, N-stearoyl-L-tyrosine inhibits the senescence of neural stem/progenitor cells induced by A1-42 via the CB2 receptor, Stem Cells Int., 2016, 7419389, 10.1155/2016/7419389 · DOI
- Lye, 2019, Astrocyte senescence may drive alterations in GFAPα, CDKN2A p14ARF, and TAU3 transcript expression and contribute to cognitive decline, Geroscience, 41, 561, 10.1007/s11357-019-00100-3 · DOI · Paper page
- Maeda, 2019, Potential of adult endogenous neural stem/progenitor cells in the spinal cord to contribute to remyelination in experimental autoimmune encephalomyelitis, Cells, 8, E1025, 10.3390/cells8091025 · DOI
- Mahmoudi, 2019, Turning back time with emerging rejuvenation strategies, Nat. Cell Biol, 21, 32, 10.1038/s41556-018-0206-0 · DOI · Paper page
- Martínez-Cué, 2020, cellular senescence in neurodegenerative diseases, Front. Cell. Neurosci., 14, 16, 10.3389/fncel.2020.00016 · DOI · Paper page
- Mei, 2016, Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery, Elife, 5, e13, 10.7554/eLife.18246.013 · doi:10.7554/elife.18246.013
- Mothe, 2005, Proliferation, migration, and differentiation of endogenous ependymal region stem/progenitor cells following minimal spinal cord injury in the adult rat, Neuroscience, 131, 177, 10.1016/j.neuroscience.2004.10.011 · DOI · Paper page
- Nakamura, 2008, Both telomeric and non-telomeric DNA damage are determinants of mammalian cellular senescence, Epigenet. Chromatin, 1, 6, 10.1186/1756-8935-1-6 · DOI · Paper page
- Neumann, 2019, Metformin restores CNS remyelination capacity by rejuvenating aged stem cells, Cell. Stem Cell. 25, 473, 10.1016/j.stem.2019.08.015 · DOI · Paper page
- Nicaise, 2019, Cellular senescence in progenitor cells contributes to diminished remyelination potential in progressive multiple sclerosis, Proc. Natl. Acad. Sci. U.S.A, 116, 9030, 10.1073/pnas.1818348116 · DOI · Paper page
- Nie, 2015, 2,3,7,8-Tetrachlorodibenzo-p-dioxin induces premature senescence of astrocytes via WNT/-catenin signaling and ROS production, J. Appl. Toxicol, 35, 851, 10.1002/jat.3084 · DOI · Paper page
- Oost, 2018, Targeting senescence to delay progression of multiple sclerosis, J. Mol. Med. (Berl)., 96, 1153, 10.1007/s00109-018-1686-x · DOI
- Papadopoulos, 2006, Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat, Exp. Neurol, 197, 373, 10.1016/j.expneurol.2005.10.033 · DOI · Paper page
- Pardo, 2017, The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations, J. Neurol, 264, 2351, 10.1007/s00415-017-8594-9 · DOI
- Patani, 2007, Remyelination can be extensive in multiple sclerosis despite a long disease course, Neuropathol. Appl. Neurobiol., 33, 277, 10.1111/j.1365-2990.2007.00805.x · DOI · Paper page
- Pertusa, 2007, Astrocytes aged in vitro show a decreased neuroprotective capacity, J. Neurochem, 101, 794, 10.1111/j.1471-4159.2006.04369.x · DOI · Paper page
- Poulsen, 2014, Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence, Ann. Rheum. Dis, 73, 1405, 10.1136/annrheumdis-2012-203146 · DOI · Paper page
- Prozorovski, 2019, Regulation of sirtuin expression in autoimmune neuroinflammation: induction of SIRT1 in oligodendrocyte progenitor cells, Neurosci. Lett, 704, 116, 10.1016/j.neulet.2019.04.007 · DOI
- Rivera, 2019, Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination, Glia, 67, 1510, 10.1002/glia.23624 · DOI
- Shen, 2008, Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency, Nat. Neurosci, 11, 1024, 10.1038/nn.2172 · DOI · Paper page
- Sim, 2002, The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation, J. Neurosci., 22, 2451, 10.1523/JNEUROSCI.22-07-02451.2002 · DOI · Paper page
- Suh, 2009, Signaling in adult neurogenesis, Annu. Rev. Cell Dev. Biol, 25, 253, 10.1146/annurev.cellbio.042308.113256 · DOI · Paper page
- Tamanini, 2018, In vivo transient and partial cell reprogramming to pluripotency as a therapeutic tool for neurodegenerative diseases, Mol. Neurobiol., 55, 6850, 10.1007/s12035-018-0888-0 · DOI
- Thewissen, 2005, Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients, Ann. N. Y. Acad. Sci, 1051, 255, 10.1196/annals.1361.066 · DOI
- Thoppil, 2020, Senolytics: a translational bridge between cellular senescence and organismal aging, Front. Cell. Dev. Biol., 7, 367, 10.3389/fcell.2019.00367 · DOI
- Trapp, 1998, Axonal transection in the lesions of multiple sclerosis, N. Engl. J. Med., 338, 278, 10.1056/NEJM199801293380502 · DOI · Paper page
- Weiss, 1996, Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis, J. Neurosci, 16, 7599, 10.1523/JNEUROSCI.16-23-07599.1996 · DOI · Paper page
- Weissert, 2013, The immune pathogenesis of multiple sclerosis, J. Neuroimmune Pharmacol, 8, 857, 10.1007/s11481-013-9467-3 · DOI
- Werner, 2001, Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage, Ann. Neurol., 50, 169, 10.1002/ana.1077 · DOI · Paper page
- Yabluchanskiy, 2020, Pharmacological or genetic depletion of senescent astrocytes prevents whole brain irradiation–induced impairment of neurovascular coupling responses protecting cognitive function in mice, Geroscience, 42, 409, 10.1007/s11357-020-00154-8 · DOI
Cited by
Oligodendrocyte progenitor cells in Alzheimer's disease: from physiology to pathology
Zou, P., Wu, C., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00385-7 · Cited by 97
Senescent Microglia: The Key to the Ageing Brain?
Greenwood, E. K., & Brown, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094402 · Cited by 84
Cellular senescence in the aging brain: A promising target for neurodegenerative diseases
Sahu, M. R., Rani, L., Subba, R., & Mondal, A. C. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111675 · Cited by 75
Molecular Mechanisms of Cellular Senescence in Neurodegenerative Diseases
Lee, H.-J., Yoon, Y.-S., & Lee, S.-J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168114 · Cited by 36
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Maupin, E. A., & Adams, K. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16301 · Cited by 12
Metadata
- Authors
- Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-06-30
- Volume
- 14
- Pages
- 178-178
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W3039523091
- Cited by
- 79
- References
- 79
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aging, Cellular Senescence, and Progressive Multiple Sclerosis. https://app.cochat.ai/papers/10.3389/fncel.2020.00178
- The paper
- Papadopoulos, D., Magliozzi, R., Mitsikostas, D. D., Gorgoulis, V. G., & Nicholas, R. S. (2020). Aging, Cellular Senescence, and Progressive Multiple Sclerosis. Frontiers in Cellular Neuroscience. https://doi.org/10.3389/fncel.2020.00178
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.